Dupilumab versus omalizumab in patients with chronic rhinosinusitis with nasal polyps and coexisting asthma (EVEREST): a multicentre, randomised, double-blind, head-to-head phase 4 trial
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-11-03 19:00:35 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-2600(25)00287-5
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260025002875
其他信息:
出版社: Elsevier BV
作者: Eugenio De Corso; G Walter Canonica; Enrico Heffler; Michal Springer; Tomasz Grzegorzek; Miguel Viana; Zsuzsanna Horváth; Joaquim Mullol; Philippe Gevaert; Justin Michel; Anju T Peters; Martin Wagenmann; Sherif Zaghloul; Mei Zhang; Mark Corbett; Scott Nash; James T Angello; Amr Radwan; Yamo Deniz; Antonio Martin; Peter W Hellings

